ASG. Aurora Spine Corp

Aurora Spine to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & 1x1 Meetings on Thursday, April 27, 2023

Aurora Spine to Present at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 & 1x1 Meetings on Thursday, April 27, 2023

Carlsbad, California, April 25, 2023 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2023 on Wednesday, April 26, 2023 at 3:00 PM (Local Time -PST). Trent Northcutt, President and CEO of Aurora Spine, will be hosting the presentation and answering questions at the conclusion.

To access the live presentation, please use the following information:

Planet MicroCap Showcase: VEGAS 2023

Date: Wednesday, April 26, 2023

Time: 6:00 PM Eastern Time (3:00 PM Pacific Time)

Webcast:

"We are pleased to be presenting the Aurora Spine story at this year's Planet MicroCap Showcase: VEGAS 2023. We are looking forward to engaging with investors and relaying the Aurora Spine story, its recent accomplishments and future growth opportunities it has to offer investors," stated Trent Northcutt, President and CEO of Aurora Spine.

If you would like to book 1x1 investor meetings with Aurora Spine and to attend the Planet MicroCap Showcase: VEGAS 2023, please make sure you are registered here:

1x1 meetings will be scheduled and conducted in person at the conference venue in LAS VEGAS.

The Planet MicroCap Showcase: VEGAS 2023 website is available here:

If you can’t make the live presentation, all company presentations “webcasts” will be available directly on the conference event platform on this link under the tab “Agenda”:


About Aurora Spine

Aurora Spine is focused on bringing new solutions to the spinal implant market through a series of innovative, minimally invasive, regenerative spinal implant technologies. Additional information can be accessed at or .

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

About Planet MicroCap

Planet MicroCap is a global multimedia financial news, publishing and events company focused on news dissemination, providing information, data and analytics for the MicroCap investing community. We have cultivated an active and engaged audience of folks that are interested in learning about and to stay ahead of the curve in the MicroCap space.

If you would like to attend the Planet MicroCap Showcase, please register here:

Contacts:

Aurora Spine Corporation

Trent Northcutt

President and Chief Executive Officer

(760) 424-2004

Chad Clouse

Chief Financial Officer

(760) 424-2004

Adam Lowensteiner

LYTHAM PARTNERS, LLC

Phoenix | New York

Telephone: 646-829-9700

Source: Aurora Spine via SNN Network



EN
25/04/2023

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Aurora Spine Corp

 PRESS RELEASE

Aurora Spine Announces Issuance of Two U.S. Patents

Aurora Spine Announces Issuance of Two U.S. Patents Tenth Issued Patent for the ZIP™ Implant Family CARLSBAD, CA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced the issuance of two independent U.S. patents by the US Patent and Trademark Office.  The issuance of these patents strengthens the company’s intellectual property portfolio and reinforces its long-term innovation strategy across multiple spinal implant platforms. New...

 PRESS RELEASE

Aurora Spine Corporation Announces Record Third Quarter Financial Resu...

Aurora Spine Corporation Announces Record Third Quarter Financial Results - Company to host conference call Today, November 18th at 11am ET/8am PT – NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced its financial results for third quarter ended September 30, 2025. All figures are in U.S. dollars. Financial and Business Highlights ...

 PRESS RELEASE

Aurora Spine Corporation Announces Participation at the North American...

Aurora Spine Corporation Announces Participation at the North American Spine Society Annual Meeting Company to Showcase Cutting-Edge Innovations at Booth #1622  CARLSBAD, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced its participation at the 2025 North American Spine Society ("NASS") Annual Meeting. The event will take place from November 14-16, 2025, at the Colorado Convention Center, in Denver, Colorado. A...

 PRESS RELEASE

Aurora Spine Launches New Biologics Portfolio

Aurora Spine Launches New Biologics Portfolio New Aurora Biologics Division Establishes Aurora Spine as a Vertically Integrated Source for Spinal Implants and Biologics CARLSBAD, CA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine”) (TSXV: ASG) (OTCQB: ASAPF), a leader in minimally invasive spine and interventional pain solutions, today announced the launch of Aurora Biologics, a new division dedicated to advancing spinal fusion success through best-in-class biologic innovation. The establishment of Aurora Biologics creates seamless synergy across Aurora’s gr...

 PRESS RELEASE

Aurora Spine Announces Proposed Warrant Extension

Aurora Spine Announces Proposed Warrant Extension CARLSBAD, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in innovative spine and interventional pain management solutions, today announces that, subject to the approval of the TSX Venture Exchange,  it is proposing to amend the terms of an aggregate of 6,445,939 common share purchase warrants (the “Warrants”) by extending the expiry date of the Warrants until October 15, 2026. The Warrants, with an exercise price of CDN$0.50 and an original expiry...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch